logologo

close

COPYRIGHT 2020 POSVAX CO. LTD. ALL RIGHTS RESERVED.

r&d

VLP-based
Anticancer Drugs

virus

Using VLP platforms, we can develop new anticancer drugs with excellent cell permeability, and improved drug usage and dose. This will decrease adverse effects and the patients can have various options for their treatment with maximized therapy effect

VLP-based Anticancer Drugs Highlights

POSVAX
VLP-BASED
ANTICANCER
DRUGS

FEATURES
  • Smart anti-cancer drug with
    low adverse effects
  • Easy to develop anticancer drugs
    for coadministration
EXPECTED
EFFECTS
  • Exploring excellent VLP
    candidates with
    high delivery ability
STATE OF
DEVELOPMENT
  • High treatment effect with
    superior drug delivery to the
    original anticancer drugs
  • Excellent cancer treatment
    preserving patients’ quality of life
FUTURE
MARKET
  • Able to enlarge anticancer drugs
    industry by concurrent therapy
    with the original drugs